Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Protara Therapeutics, Inc.
NASDAQ:TARAHealthcare · Biotechnology
-1.59%$2.48
AH$2.52+1.61%vs close
Mkt Cap$146.56M
Float57.78M
O/S59.1M
Vol
$ Vol
RVOL
Inst Own77.9%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$57.44M
Total Assets$209.47M
Free Cash Flow-$56.46M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$3.36M
Total Equity$196.41M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in TARA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$209.47M
Liabilities$13.06M
Accounts Receivable$1.26M
Accounts Payable$3.47M
Inventory$0
PP&E (Net)$3.93M
Goodwill$0
Intangible Assets$2.93M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.95M | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $362K | $0 | $341K | $0 | $0 | $196K | $16K | $115K | $148K | $123K | $57K | $0 | $27K | $57K |
| Gross Profit | -$362K | $0 | -$341K | $0 | $0 | -$196K | -$16K | -$115K | -$148K | -$123K | -$57K | $2.95M | -$27K | -$57K |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | 100.0% | - | - |
| Research and Development | $42.63M | $31.7M | $24.79M | $16.81M | $21.09M | $11.88M | $6.44M | $15.51M | $21.69M | $18.87M | $12.38M | $6.43M | $3.99M | $5.91M |
| Selling, General, and Administrative | $21.92M | $17.45M | $18.62M | $20.74M | $26.4M | $22.36M | $8.82M | $10.57M | $8.53M | $9.71M | $8.43M | $4.1M | $3.1M | $2.03M |
| Other | -$362K | $0 | -$137K | $29.52M | $0 | $0 | $0 | $207K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $64.19M | $49.15M | $43.27M | $67.06M | $47.49M | $34.25M | $15.25M | $26.08M | $30.21M | $28.58M | $20.81M | $10.53M | $7.09M | $7.94M |
| Operating Income (EBIT) | -$64.55M | -$49.15M | -$43.61M | -$67.06M | -$47.49M | -$34.44M | -$15.25M | -$26.08M | -$30.36M | -$28.7M | -$20.87M | -$7.58M | -$7.12M | -$8M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | -257.1% | - | - |
| Interest Expense | $0 | $0 | $0 | $1.14M | $1.74M | $34K | $0 | $0 | $259K | $193K | $144K | $857K | $861K | $0 |
| Interest Income | $6.33M | $4.13M | $2.73M | $1.11M | $237K | $466K | $0 | $0 | $0 | $0 | $0 | $0 | $4K | $20K |
| Other Income (Expense) | $7.11M | $4.56M | $3.19M | $1.11M | $237K | $466K | $0 | $643K | $398K | $179K | -$507K | $4.24M | -$790K | $26K |
| Income Before Tax (EBT) | -$57.44M | -$44.6M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$14.99M | -$25.44M | -$29.96M | -$28.53M | -$21.38M | -$3.34M | -$7.91M | -$7.97M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$262K | $5.35M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$57.44M | -$44.6M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$14.99M | -$25.44M | -$29.96M | -$28.53M | -$21.38M | -$3.34M | -$7.91M | -$7.97M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | -113.4% | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -1.34 | -2.17 | -3.57 | -5.86 | -4.20 | -4.70 | -3.63 | -9.93 | -69.38 | -68.90 | -51.94 | -10.24 | -37.43 | -37.62 |
| Diluted EPS | -1.34 | -2.17 | -3.57 | -5.86 | -4.20 | -4.70 | -3.63 | -9.93 | -69.38 | -68.90 | -51.94 | -10.24 | -37.43 | -37.62 |
| Weighted Average OS | 42.84M | 20.59M | 11.33M | 11.26M | 11.23M | 7.23M | 4.06M | 2.56M | 431,858 | 414,044 | 411,603 | 326,212 | 374,847 | 374,847 |
| EBITDA | -$57.08M | -$44.26M | -$40.08M | -$64.57M | -$45.4M | -$33.78M | -$7.81M | -$20.61M | -$29.82M | -$28.4M | -$21.32M | -$2.46M | -$7.02M | -$7.91M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | -83.3% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $49.66M | $162.8M | $39.59M | $24.13M | $35.72M | $168.6M | $6.18M | $19.37M | $21.17M | $36.39M | $40.03M | $68.84M | $2.83M | $2.41M |
| Short-Term Investments | $105.9M | $7.49M | $25.99M | $60.24M | $55.51M | $0 | $0 | $2.5M | $20.97M | $4.92M | $25.23M | $14.76M | $2.36M | $5.1M |
| Cash and Short-Term Investments | $155.55M | $170.29M | $65.58M | $84.37M | $91.23M | $168.6M | $6.18M | $21.87M | $42.14M | $41.32M | $65.26M | $83.59M | $5.19M | $7.51M |
| Accounts Receivable | $1.26M | $0 | $242K | $486K | $634K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1.16M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $65K | $2K | $37K | -$1.04M | $34K | $102K | $716K | $0 | $22.31M | $6.36M | $26.58M | $15.76M | $78K | $41K |
| Total Current Assets | $159.5M | $172.16M | $68.7M | $86.15M | $93.11M | $169.44M | $6.97M | $23.24M | $43.48M | $42.76M | $66.61M | $84.6M | $5.33M | $7.7M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $3.93M | $5.28M | $6.56M | $7.87M | $8.89M | $2.3M | $459K | $263K | $259K | $372K | $224K | $83K | $62K | $79K |
| Goodwill | $0 | $0 | $0 | $0 | $29.52M | $29.52M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2.93M | $3.25M | $2.66M | $84K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $42.34M | $0 | $0 | $17.89M | $39.47M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $267K | $0 |
| Other Long-Term Assets | $765K | $772K | $1.03M | $1.3M | $1.61M | $1.91M | $122K | $22K | $240K | $393K | $706K | $114K | $0 | $0 |
| Total Long-Term Assets | $49.96M | $9.3M | $10.25M | $27.14M | $79.48M | $33.72M | $581K | $285K | $499K | $765K | $930K | $197K | $329K | $79K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | -$581K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $209.47M | $181.45M | $78.95M | $113.29M | $172.6M | $203.16M | $6.97M | $23.52M | $43.98M | $43.52M | $67.54M | $84.8M | $5.66M | $7.78M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $3.47M | $4.43M | $2.43M | $1.59M | $954K | $914K | $716K | $441K | $0 | $0 | $0 | $0 | $399K | $469K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $20K | $0 | $0 | $0 | $5.06M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $41K | $159K | $0 | $0 | $0 | $0 | $0 | $0 | $267K | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$28K | $0 | $0 | $0 | $2.95M | $0 |
| Other Current Liabilities | $3.27M | $2.53M | $2.11M | $2.54M | $1.8M | $1.53M | -$137K | $0 | $7.89M | $3.94M | $4.13M | $1.7M | $677K | $654K |
| Total Current Liabilities | $10.94M | $10.96M | $6.15M | $5.74M | $4.3M | $2.92M | $583K | $3.08M | $9.24M | $5.08M | $4.13M | $2.34M | $9.77M | $1.2M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.95M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.12M | $3.36M | $4.48M | $5.47M | $6.38M | $999K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.95M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $13.06M | $14.32M | $10.63M | $11.21M | $10.68M | $3.91M | $583K | $3.08M | $9.24M | $5.08M | $4.13M | $2.34M | $9.77M | $4.15M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $18.46M | $21.52M | $21.52M | $548K | $0 | $84.8M | $96.41M | $90.29M |
| Common Stock | $54K | $35K | $11K | $11K | $11K | $11K | $3K | $19K | $18K | $17K | $16K | $16K | $0 | $0 |
| Retained Earnings | -$302.42M | -$244.98M | -$200.38M | -$159.96M | -$94.01M | -$46.76M | -$225.46M | -$210.47M | -$189.74M | -$159.78M | -$131.25M | -$109.87M | -$100.51M | -$86.66M |
| Comprehensive Income & Other | $90K | $2K | -$31K | -$688K | -$211K | $0 | $3K | $5K | -$14K | -$565K | -$11K | -$12K | $0 | $1K |
| Other Stockholders' Equity | $498.78M | $412.08M | $268.69M | $262.04M | $255.91M | $245.99M | $231.85M | $230.89M | $224.46M | $198.2M | $194.64M | $192.32M | $96.41M | $90.29M |
| Total Equity | $196.41M | $167.13M | $68.32M | $102.08M | $161.91M | $199.24M | $6.39M | $20.44M | $34.74M | $38.44M | $63.41M | $82.46M | -$4.11M | $3.63M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $209.47M | $181.45M | $78.95M | $113.29M | $172.6M | $203.16M | $6.97M | $23.52M | $43.98M | $43.52M | $67.54M | $84.8M | $5.66M | $7.78M |
| Supplementary Data | ||||||||||||||
| Total Debt | $3.36M | $4.48M | $5.47M | $6.38M | $7.24M | $1.09M | $0 | $0 | $20K | $0 | $0 | $0 | $5.06M | $0 |
| Net Debt | -$46.3M | -$158.31M | -$34.12M | -$17.74M | -$28.48M | -$167.51M | -$6.18M | -$19.37M | -$21.15M | -$36.39M | -$40.03M | -$68.84M | $2.23M | -$2.41M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$57.44M | -$44.6M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$14.99M | -$20.73M | -$29.96M | -$28.53M | -$21.38M | -$3.34M | -$7.91M | -$7.97M |
| Depreciation & Amortization | $362K | $332K | $341K | $248K | $117K | $196K | $16K | $115K | $148K | $123K | $57K | $30K | $27K | $57K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$9.94M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $3.83M | $4.13M | $6.09M | $6.69M | $10.36M | $9.75M | $943K | $3.43M | $926 | $3.34M | $2.16M | $459K | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $17K | $49K | -$46K | -$26K | -$32K | $0 | $1K | $28K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | -$17K | $0 | -$41.79M | -$63.52M | -$83.49M | $0 | $0 | $0 |
| Accounts Payable | -$873K | $1.38M | $848K | $631K | $40K | $198K | -$2.5M | -$6.16M | $4.16M | $1.07M | $1.26M | $955K | $177K | -$912K |
| Other Working Capital | -$2.07M | $2.63M | -$4.99M | -$92K | $494K | $431K | $625K | $190K | $4.46M | $1.32M | $359K | -$846K | $183K | $320K |
| Total Working Capital Change | -$2.94M | $4.01M | -$4.14M | $539K | $534K | $629K | -$1.87M | -$5.97M | $4.41M | $1.29M | $327K | $109K | $361K | -$564K |
| Other Non-Cash Items | -$173K | $324K | $569K | $32.02M | $1.74M | $9.94M | $259K | -$76K | $3.39M | $3.69M | $3.57M | -$7.25M | $821K | $243K |
| Net Cash from Operating | -$56.37M | -$35.81M | -$37.56M | -$26.46M | -$34.5M | -$23.41M | -$15.65M | -$23.23M | -$22.35M | -$23.69M | -$17.57M | -$9.99M | -$6.7M | -$8.23M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$94K | -$63K | -$45K | -$120K | -$596K | -$884K | -$16K | -$119K | -$35K | -$271K | -$198K | -$51K | -$10K | -$67K |
| Acquisitions | $0 | $0 | $0 | -$15K | $98K | $3.72M | $0 | $0 | $0 | $0 | $0 | $0 | $65K | $33K |
| Purchases of Investments | -$204.63M | -$29.38M | -$12.19M | -$43.55M | -$124.75M | $0 | $0 | -$15.44M | -$32.94M | -$39.76M | -$88.64M | -$34.95M | -$3.88M | -$8.66M |
| Sales of Investments | $65.23M | $48.6M | $65.34M | $58.62M | $27.15M | $0 | $2.5M | $33.99M | $16.88M | $59.94M | $77.51M | $22.52M | $6.55M | $16.07M |
| Other Investing Activities | $0 | $0 | $0 | $15K | -$98K | $0 | $0 | $0 | $0 | $0 | $2.01M | $0 | $0 | -$1K |
| Net Cash from Investing | -$139.49M | $19.16M | $53.11M | $14.95M | -$98.19M | $2.83M | $2.48M | $18.43M | -$16.1M | $19.92M | -$11.33M | -$12.48M | $2.73M | $7.38M |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $82.9M | $136.01M | $0 | $0 | $0 | $87.85M | $500K | $2.85M | $1.53M | $208K | $163K | $88.52M | $21K | $0 |
| Common Stock Repurchases | $0 | $0 | -$91K | -$90K | -$228K | $0 | $0 | $0 | $0 | $208K | $163K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$185K | $3.86M | $0 | $0 | $0 | $11.62M | $0 | $132K | $21.52M | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $82.72M | $139.87M | -$91K | -$90K | -$228K | $189.4M | $500K | $2.98M | $23.05M | $208K | $163K | $88.52M | $4.36M | -$9K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | -$500K | $22K | $180K | -$76K | -$75K | $0 | $0 | $0 |
| Net Change in Cash | -$113.14M | $123.21M | $15.46M | -$11.6M | -$132.92M | $168.83M | -$13.16M | -$1.8M | -$15.22M | -$3.64M | -$28.81M | $66.05M | $0 | $0 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$56.37M | -$35.81M | -$37.56M | -$26.46M | -$34.5M | -$23.41M | -$15.65M | -$23.23M | -$22.35M | -$23.69M | -$17.57M | -$9.99M | -$6.7M | -$8.23M |
| Capital Expenditure | -$94K | -$63K | -$45K | -$120K | -$596K | -$884K | -$16K | -$119K | -$35K | -$271K | -$198K | -$51K | -$10K | -$67K |
| Free Cash Flow | -$56.46M | -$35.87M | -$37.6M | -$26.58M | -$35.1M | -$24.29M | -$15.66M | -$23.35M | -$22.39M | -$23.96M | -$17.76M | -$10.04M | -$6.71M | -$8.3M |
| Cash at Beginning | $163.54M | $40.33M | $24.87M | $36.47M | $169.39M | $564K | $19.39M | $21.19M | $36.39M | $40.03M | $68.84M | $2.79M | $2.41M | $0 |
| Cash at End | $50.4M | $163.54M | $40.33M | $24.87M | $36.47M | $169.39M | $6.23M | $19.39M | $21.17M | $36.39M | $40.03M | $68.84M | $2.83M | $2.41M |